Project Details
Projekt Print View

Selectively Antibacterial Silver-Gold Alloy Nanoparticles Conjugated with Target Specific Aptamer Sequences

Subject Area Biomaterials
Synthesis and Properties of Functional Materials
Term from 2018 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 356685838
 
Final Report Year 2024

Final Report Abstract

Implant-associated infections are a challenge in medicine and arise from bacteria that organize themselves into resistant biofilms. Limitations of current therapeutic approaches are that their effect on bacteria is also associated with a risk to human cells. Therefore, there is a need for antibacterial strategies with an extended therapeutic window. For this purpose, this project developed silver-gold alloy nanoparticle (AgAu NP)-aptamer conjugates designed to I) release antimicrobial silver ions, and II) bind to pathogenic bacteria in biofilm via a specific aptamer. A size-controlled synthesis of AgAu NP could be achieved by laser ablation in liquids. Alloy particle surface composition was characterized in-depth by XPS and cyclic voltammetry. A protocol for the conjugation of thiolated aptamers to AgAu NP and in vitro functional assays for the conjugates was developed. The maximum functionality was hardly affected by the Ag:Au ratio in the particle, but selective binding of the conjugates to the target protein A, predicted in the literature, could not be reproduced. The study of ion release in gel phantoms showed a significant reduction in the presence of the aptamer ligands. Collaborative single-particle hyperspectroscopy studies with Mercator Fellow Stephan Link established trends for composition-dependent particle dissolution and derived a two-step model for the dissolution kinetics of AgAu NP. Biological analysis of AgAu NP and corresponding conjugates showed antibacterial effects against Staphylococcus aureus and Porphyromonas gingivalis. Detailed studies demonstrated a dependence of the effect on nanoparticle concentration and bacterial growth phase, especially biofilm formation. By applying activity assays, membrane staining, and gene expression analysis, bacterial metabolism was identified as the major target of AgAu NP. The nanoparticles also exhibited cytotoxic effects against human fibroblasts and keratinocytes, which, however, were attenuated when cells and bacteria were cocultured. Overall, this project provided fundamental chemical and biological insights into AgAu NP as antibiotic alternatives and identified key approaches for further development toward clinical application.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung